Bowel Cancer and Biomarker Laboratory, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.
Shimadzu Scientific Instruments Australia, Unit F, 10-16 South Street, Rydalmere 2116, New South Wales, Australia.
J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Feb 15;1217:123618. doi: 10.1016/j.jchromb.2023.123618. Epub 2023 Jan 27.
The gut microbiome produces a range of short chain fatty acids (SCFA) crucially linked with diet and nutrition, metabolism, gastrointestinal health and homeostasis. SCFA are primarily measured using gas or liquid chromatography-mass spectrometry (LC/MS) after undergoing chemical derivatization. Here we assess the merits of a derivatization protocol using aniline and two aniline analogues (3-phenoxyaniline and 4-(benzyloxy)aniline) for the targeted LC-MS/MS quantification of nine SCFA (acetic, propionic, butyric, valeric, caproic acid, isobutyric, isovaleric, 2-methylbutyric, and 2-ethylbutyric acid). Evaluation of product ion spectra and optimization of MS detection conditions, provided superior detection sensitivity for 3-phenoxyaniline and 4-(benzyloxy)aniline compared to aniline. We developed a facile SCFA derivatization method using 3-phenoxyaniline under mild reaction conditions which allows for the simultaneous quantification of these SCFA in human stool samples in under eleven minutes using multiple reaction monitoring LC-MS/MS. The method was successfully validated and demonstrates intra- and inter-day accuracy (88.5-103% and 86.0-109%) and precision (CV of 0.55-7.00% and 0.33-9.55%) with recoveries (80.1-87.2% for LLOQ, 88.5-93.0% for ULOQ) and carry-over of (2.68-17.9%). Selectivity, stability and matrix effects were also assessed and satisfied validation criteria. Method applicability was demonstrated by analysing SCFA profiles in DNA-stabilized human stool samples from newly diagnosed colorectal cancer patients prior to surgery. The development of this improved method and its compatibility to measure SCFAs from DNA-stabilized stool will facilitate studies investigating the gut microbiome in health and disease.
肠道微生物群产生一系列短链脂肪酸(SCFA),这些脂肪酸与饮食和营养、代谢、胃肠道健康和体内平衡密切相关。SCFA 主要通过化学衍生化后使用气相或液相色谱-质谱联用(LC/MS)进行测量。在这里,我们评估了使用苯胺和两种苯胺类似物(3-苯氧基苯胺和 4-(苯氧基)苯胺)进行衍生化的方案的优点,用于靶向 LC-MS/MS 定量分析九种 SCFA(乙酸、丙酸、丁酸、戊酸、己酸、异丁酸、异戊酸、2-甲基丁酸和 2-乙基丁酸)。对产物离子光谱的评估和 MS 检测条件的优化,为 3-苯氧基苯胺和 4-(苯氧基)苯胺提供了比苯胺更高的检测灵敏度。我们在温和的反应条件下使用 3-苯氧基苯胺开发了一种简便的 SCFA 衍生化方法,该方法允许在不到十一分钟的时间内使用多重反应监测 LC-MS/MS 同时定量分析人粪便样本中的这些 SCFA。该方法已成功验证,并证明具有日内和日间准确性(88.5-103%和 86.0-109%)和精密度(0.55-7.00%和 0.33-9.55%),回收率(LLOQ 为 80.1-87.2%,ULOQ 为 88.5-93.0%)和交叉污染(2.68-17.9%)。还评估了选择性、稳定性和基质效应,并满足验证标准。通过分析手术前新诊断的结直肠癌患者 DNA 稳定的人粪便样本中的 SCFA 谱,证明了该方法的适用性。该改进方法的开发及其与测量 DNA 稳定粪便中 SCFA 的兼容性将促进研究健康和疾病中的肠道微生物群。